Tan Wan C, Hague Cameron J, Leipsic Jonathon, Bourbeau Jean, Zheng Liyun, Li Pei Z, Sin Don D, Coxson Harvey O, Kirby Miranda, Hogg James C, Raju Rekha, Road Jeremy, O'Donnell Denis E, Maltais Francois, Hernandez Paul, Cowie Robert, Chapman Kenneth R, Marciniuk Darcy D, FitzGerald J Mark, Aaron Shawn D
Center for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Department of Radiology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
PLoS One. 2016 Nov 18;11(11):e0166745. doi: 10.1371/journal.pone.0166745. eCollection 2016.
Thoracic computed tomography (CT) scans are widely performed in clinical practice, often leading to detection of airway or parenchymal abnormalities in asymptomatic or minimally symptomatic individuals. However, clinical relevance of CT abnormalities is uncertain in the general population.
We evaluated data from 1361 participants aged ≥40 years from a Canadian prospective cohort comprising 408 healthy never-smokers, 502 healthy ever-smokers, and 451 individuals with spirometric evidence of chronic obstructive pulmonary disease (COPD) who had thoracic CT scans. CT images of subjects were visually scored for respiratory bronchiolitis(RB), emphysema(E), bronchial-wall thickening(BWT), expiratory air-trapping(AT), and bronchiectasis(B). Multivariable logistic regression models were used to assess associations of CT features with respiratory symptoms, dyspnea, health status as determined by COPD assessment test, and risk of clinically significant exacerbations during 12 months follow-up.
About 11% of life-time never-smokers demonstrated emphysema on CT scans. Prevalence increased to 30% among smokers with normal lung function and 36%, 50%, and 57% among individuals with mild, moderate or severe/very severe COPD, respectively. Presence of emphysema on CT was associated with chronic cough (OR,2.11; 95%CI,1.4-3.18); chronic phlegm production (OR,1.87; 95% CI,1.27-2.76); wheeze (OR,1.61; 95% CI,1.05-2.48); dyspnoea (OR,2.90; 95% CI,1.41-5.98); CAT score≥10(OR,2.17; 95%CI,1.42-3.30) and risk of ≥2 exacerbations over 12 months (OR,2.17; 95% CI, 1.42-3.0).
Burden of thoracic CT abnormalities is high among Canadians ≥40 years of age, including never-smokers and smokers with normal lung function. Detection of emphysema on CT scans is associated with pulmonary symptoms and increased risk of exacerbations, independent of smoking or lung function.
胸部计算机断层扫描(CT)在临床实践中广泛应用,常常能在无症状或症状轻微的个体中检测到气道或实质异常。然而,在普通人群中,CT异常的临床相关性尚不确定。
我们评估了来自加拿大一个前瞻性队列中1361名年龄≥40岁参与者的数据,该队列包括408名健康的从不吸烟者、502名健康的曾经吸烟者以及451名有肺功能测定证据表明患有慢性阻塞性肺疾病(COPD)的个体,这些人都进行了胸部CT扫描。对受试者的CT图像进行视觉评分,评估呼吸性细支气管炎(RB)、肺气肿(E)、支气管壁增厚(BWT)、呼气性气体陷闭(AT)和支气管扩张(B)情况。使用多变量逻辑回归模型评估CT特征与呼吸症状、呼吸困难、由COPD评估测试确定的健康状况以及12个月随访期间临床显著加重风险之间的关联。
约11%的终生不吸烟者在CT扫描中显示有肺气肿。在肺功能正常的吸烟者中,患病率增至30%,在轻度、中度或重度/极重度COPD患者中分别为36%、50%和57%。CT上存在肺气肿与慢性咳嗽(比值比[OR],2.11;95%置信区间[CI],1.4 - 3.18)、慢性咳痰(OR,1.87;95% CI,1.27 - 2.76)、喘息(OR,1.61;95% CI,1.05 - 2.48)、呼吸困难(OR,2.90;95% CI,1.41 - 5.98)、COPD评估测试(CAT)评分≥10(OR,2.17;95% CI,1.42 - 3.30)以及12个月内≥2次加重的风险(OR,2.17;95% CI,1.42 - 3.0)相关。
在40岁及以上的加拿大人中,胸部CT异常的负担很高,包括从不吸烟者和肺功能正常的吸烟者。CT扫描中肺气肿的检测与肺部症状及加重风险增加相关,与吸烟或肺功能无关。